Risk of recurrence during follow-up for optimally treated advanced epithelial ovarian cancer (EOC) with a low-level increase of serum CA-125 levels

1. Prat, A.
2. Parera, M.
3. Adamo, B.
4. Peralta, S.
5. Perez-Benavente, M.A.
6. Garcia, A.
7. Gil-Moreno, A.
8. Martinez-Palones, J.M.
9. Baselga, J.
10. del Campo, J.M.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/ANNONC/MDN601 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus